Insider Transactions in Q1 2019 at Accenture PLC (ACN)
Insider Transaction List (Q1 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2019
|
Tracey Thomas Travis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,764
+28.76%
|
-
|
|
Feb 01
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Payment of exercise price or tax liability
|
Direct |
1,668
-1.28%
|
$256,872
$154.44 P/Share
|
|
Feb 01
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct |
2,000
-1.52%
|
$310,000
$155.0 P/Share
|
|
Jan 25
2019
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,883
-9.53%
|
$435,333
$151.75 P/Share
|
|
Jan 18
2019
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,916
-8.79%
|
$437,400
$150.0 P/Share
|
|
Jan 18
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
1,172
-3.03%
|
$175,800
$150.0 P/Share
|
|
Jan 18
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct |
2,000
-1.49%
|
$300,000
$150.0 P/Share
|
|
Jan 17
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Indirect |
1,000
-50.0%
|
$148,000
$148.48 P/Share
|
|
Jan 17
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
1,000
-0.74%
|
$148,000
$148.48 P/Share
|
|
Jan 07
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Open market or private sale
|
Direct |
3,610
-5.54%
|
$509,010
$141.36 P/Share
|
|
Jan 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
195
-0.47%
|
$27,105
$139.42 P/Share
|
|
Jan 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
987
+1.17%
|
$68,103
$69.71 P/Share
|
|
Jan 05
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
448
-4.05%
|
$62,272
$139.42 P/Share
|
|
Jan 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,377
+5.74%
|
$95,013
$69.71 P/Share
|
|
Jan 05
2019
|
Chad T Jerdee General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-2.19%
|
$48,233
$139.42 P/Share
|
|
Jan 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+3.59%
|
$83,007
$69.71 P/Share
|
|
Jan 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,059
-3.07%
|
$147,201
$139.42 P/Share
|
|
Jan 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
2,290
+3.16%
|
$158,010
$69.71 P/Share
|
|
Jan 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Payment of exercise price or tax liability
|
Direct |
1,197
-0.88%
|
$166,383
$139.42 P/Share
|
|
Jan 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
4,963
+1.8%
|
$342,447
$69.71 P/Share
|
|
Jan 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
935
-2.36%
|
$129,965
$139.42 P/Share
|
|
Jan 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,127
+2.58%
|
$146,763
$69.71 P/Share
|
|
Jan 05
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-1.73%
|
$54,071
$139.42 P/Share
|
|
Jan 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,320
+2.8%
|
$91,080
$69.71 P/Share
|
|
Jan 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Payment of exercise price or tax liability
|
Direct |
1,356
-1.0%
|
$188,484
$139.42 P/Share
|
|
Jan 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
2,640
+0.96%
|
$182,160
$69.71 P/Share
|
|
Jan 01
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
2,780
-6.36%
|
$389,200
$140.34 P/Share
|
|
Jan 01
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+10.89%
|
-
|
|
Jan 01
2019
|
Gianfranco Casati CEO-Growth Markets |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+9.4%
|
-
|
|
Jan 01
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-1.68%
|
$23,100
$140.34 P/Share
|
|
Jan 01
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,685
+21.43%
|
-
|
|
Jan 01
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.27%
|
$29,680
$140.34 P/Share
|
|
Jan 01
2019
|
Johan Deblaere Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+6.45%
|
-
|
|
Jan 01
2019
|
Chad T Jerdee General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
843
-5.43%
|
$118,020
$140.34 P/Share
|
|
Jan 01
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
3,740
+19.42%
|
-
|
|
Jan 01
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,712
-5.04%
|
$239,680
$140.34 P/Share
|
|
Jan 01
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+13.61%
|
-
|
|
Jan 01
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+3.91%
|
-
|
|
Jan 01
2019
|
Pierre Nanterme Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,158
+5.88%
|
-
|
|
Jan 01
2019
|
Jean Marc Ollagnier CEO EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
43
-0.03%
|
$6,020
$140.34 P/Share
|
|
Jan 01
2019
|
Jean Marc Ollagnier CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+3.03%
|
-
|
|
Jan 01
2019
|
David Rowland Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
8,728
+20.83%
|
-
|
|
Jan 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
494
-1.3%
|
$69,160
$140.34 P/Share
|
|
Jan 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,740
+8.96%
|
-
|
|
Jan 01
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,336
-5.93%
|
$187,040
$140.34 P/Share
|
|
Jan 01
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+19.17%
|
-
|
|
Jan 01
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Payment of exercise price or tax liability
|
Direct |
786
-0.59%
|
$110,040
$140.34 P/Share
|
|
Jan 01
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+3.85%
|
-
|